Mr. Ken d'Entremont reports

MEDEXUS SCHEDULES FOURTH FISCAL QUARTER AND FISCAL YEAR 2023 CONFERENCE CALL

Medexus Pharmaceuticals Inc. plans to host a conference call at 8 a.m. Eastern Time on Thursday, June 22, 2023, to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2023. Medexus expects to file its financial statements and management's discussion and analysis after markets close on June 21, 2023.

To participate in the call, please dial the following numbers.

Toll-free for Canadian and U.S. callers:  888-506-0062

For international callers:  1-973-528-0011

Access code:  199383

A live webcast of the call will be available on the investors section of Medexus's corporate website.

A replay of the call will be available approximately one hour following the end of the call through Thursday, June 29, 2023. To listen to the replay, please dial the following numbers.

For Canadian and U.S. callers:  877-481-4010

For international callers:  1-919-882-2331

Conference ID:  48579

A replay of the webcast will be available in the investors section of Medexus's corporate website until Saturday, June 22, 2024.

About Medexus Pharmaceuticals Inc.

Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy and dermatology.

We seek Safe Harbor.